Boas Strategic Advisors

12/07/2025

If your a CEO and your asking: "What’s our AI plan for 2026?”, could you answer with confidence?

I have the answer: Better Together – Your Solution to All Things AI in Pharma

I bring 35+ years of pharma leadership (Sales, Marketing, Medical).

My partner, Erik Schwartz, brings 30+ years of AI leadership (Elsevier, Microsoft, Comcast), implementing AI at scale in highly regulated environments.

Together, we help pharma leaders move from AI noise to clear, actionable workflows that create real impact, not science projects.

If you or your leadership team expects the teams to “do something with AI” and you don’t have a lot of time, let’s talk. A focused 30 minutes could change how you think about AI for your teams.

Final question:
What’s the one workflow in your world you wish AI could fix first?

12/07/2025

As your looking everyday to be GREAT- here is a solution that is "Where and When You Need It"- High Quality Deliverables with a "Broad Scope of Capabilities"!

As your looking everyday to be GREAT- here is a solution that is "Where and When You Need It"- High Quality Deliverables with a "Broad Scope of Capabilities"!

12/07/2025

CONTENT CREATORS: When you can spend less time hunting references and more time thinking scientifically, everyone wins.

If you want to see MACg in action, just reach out, I can get you a 30-minute demo with Ome.

CONTENT CREATORS: When you can spend less time hunting references and more time thinking scientifically, everyone wins. If you want to see MACg in action, just reach out, I can get you a 30-minute demo with Ome.

12/07/2025

This week’s big takeaway: "AI ADOPTION STARTS WITH CLARITY OF THE PROBLEM, NOT FASCINATION WITH THE TECHNOLOGY!"

Learning Lesson from MIT- "AI: Implications for Business Strategy” (Module 2)

One of my professors put it this way: "Most leaders are starting with the AI platform that their company has and then they see what problem/challenge it can solve", but he emphasized that leaders should “start with a business problem or customer need that can be met with machine learning.” and then go out into the market to see which AI platform is best to solve that problem.

Another professor stated that "machine learning will change every industry, and all leaders need to work everyday to an understanding of both its potential and its limits".

So, the lesson learned: EFFECTIVE AI ADOPTION STARTS WITH CLARITY OF THE PROBLEM, NOT FASCINATION WITH THE TECHNOLOGY".

Where do you see the most untapped opportunities for AI to solve business challenges in your organization today?

Mike Boas
Boas Strategic Advisors

12/07/2025

Do you believe one accountable leader can truly transform a company’s growth engine? (Please comment below)

After over 35 years I can confidently say that most companies don’t have a science problem; they have an alignment problem.

This is why the Chief Revenue Officer (CRO) role is rapidly expanding across both Pharma and biotech manufacturers, as well as Service Providers.

Here’s the reality:

Before a CRO/CGO:
- 15–25% efficiency loss (Deloitte)
- Forecast accuracy below 55% (SBI)

After a CRO/CGO:
- There is one accountable owner.
- There is one strategy and one leader
- There is one unified approach.

The results improve significantly:
+20–30% stronger launch ex*****on (McKinsey)
+15–25% revenue productivity lift (McKinsey)

THE MOST IMPORTANT NUMBER:
- 3x–6x ROI over a 12–24-month period, driven by:
- Faster decision-making.
- Increased business valuation
- Risk mitigation

If you’re a CEO, ask yourself this:
- Are your teams relying on heroic individuals to hold everything together?

If you’d like to explore whether a CRO could create measurable ROI in your organization, DM me “CRO.”

Mike Boas

12/06/2025

Question for CEOs and Boards:
Are you preparing for AI, or for the agentic era where AI doesn’t just assist work, but performs it?

3 takeaways leaders can’t ignore heading into 2026:

1. We’re in the “pause before the leap.”

Early gen-AI pilots underperformed, so many leaders pulled back. But agentic AI systems that can plan, act, learn, and coordinate, is accelerating. This is the window to move ahead, not wait.

2. The value isn’t in automating tasks, it’s in redesigning workflows.

Automating tasks gives you 3–5%.
Rebuilding end-to-end workflows with coordinated agents delivers step-change performance. This is where competitive separation happens.

3. Every leader becomes an “agent leader.”
Teams will manage agents like talent, setting goals, reviewing work, correcting outputs, and owning outcomes. New skills. New KPIs. New operating models.

If you’re a CEO or board member, this report is a must-read.

This moment is not about technology, it’s about leadership, governance, and how your business will operate over the next 24 months.

As you shape your 2026 AI strategy, I can help you:
• Identify where agentic AI truly fits
• Prioritize high-ROI workflows
• Build governance and operating models that keep humans in charge

Final question:
Where are you seeing the biggest uncertainty today: strategy, capability, or governance?

If you’d like a sounding board as you navigate this shift, reach out anytime.

Mike Boas | Boas Strategic Advisors
610-787-1558 | boas.gmike@gmail.com

https://www.mckinsey.com/capabilities/quantumblack/our-insights/the-change-agent-goals-decisions-and-implications-for-ceos-in-the-agentic-age

12/06/2025

"People before Projects": Investing in What’s Next: for My Clients and for Pharma Leadership.

I decided to invest my hard earned money & limited weekend time and enrolled in the MIT Sloan Executive Education "Artificial Intelligence: Implications for Business Strategy” program.

AI is transforming how pharma and life sciences organizations innovate, operate, and communicate. To be the best strategic advisor I can be to guide executive teams effectively, I decided I must understand its business implications and pathways to real-world impact.

In addition to my US/Global Marketing, Medical & Sales experience, this program strengthens my ability to help CEOs, CFOs, CMOs, Marketing and Medical leaders harness AI to accelerate innovation, improve decision-making, and build future-ready organizations.

ACTIONS:
1) Do you need AI support/guidance RIGHT NOW for 2026 Planning? Please reach out to me!

I have painstakingly evaluated many AI thought leaders and selected to partner with the best of the best, including:
- Erik Schwartz Founder - TheAiExpert.ai
- Ome Ogbru, PharmD CEO & Founder AINGENS(MACg)
- David Mondgock: Founding Partner - Catalyst IQ

2) Do you need a Fractional CMO, CRO or Marketing/Medical Leader with experience to fill a leadership gap? Please reach out to me!

12/06/2025

"People Before Projects": Turning Personal Mantra into Personal Action: Wharton Executive Leadership Program at the University of Pennsylvania.

I am proud to say I have successfully completed the Wharton School Executive Leadership Program.

This immersive 7-month program provided a multi-module development experience aimed at enhancing strategic business capabilities.

Throughout the program, each session concentrated on enhancing strategic business leadership skills, covering key areas such as Enterprise Leadership, Vision & Strategy, Driving Performance, and Influence & Persuasion.

I am proud to say that this experience has greatly bolstered my strategic business acumen.